Immunity to influenza A virus infection in young children: a comparison of natural infection, live cold-adapted vaccine, and inactivated vaccine.
about
Live, attenuated influenza A H5N1 candidate vaccines provide broad cross-protection in mice and ferretsThe relative efficacy of trivalent live attenuated and inactivated influenza vaccines in children and adultsViral Inhibition of the IFN-Induced JAK/STAT Signalling Pathway: Development of Live Attenuated Vaccines by Mutation of Viral-Encoded IFN-AntagonistsThe population impact of a large school-based influenza vaccination campaignAntibody response of healthy children to pandemic A/H1N1/2009 influenza virusSeasonal trivalent inactivated influenza vaccine protects against 1918 Spanish influenza virus infection in ferrets.B cell responses to H5 influenza HA in human subjects vaccinated with a drifted variantA respiratory syncytial virus (RSV) vaccine based on parainfluenza virus 5 (PIV5).Pharmacologic advances in the treatment and prevention of respiratory syncytial virus.The development of live attenuated cold-adapted influenza virus vaccine for humans.Synthetic double-stranded RNA poly(I:C) combined with mucosal vaccine protects against influenza virus infection.Characterization of attenuated coxsackievirus B3 strains and prospects of their application as live-attenuated vaccines.Effectiveness of reverse transcription-PCR, virus isolation, and enzyme-linked immunosorbent assay for diagnosis of influenza A virus infection in different age groups.Mucosal immunity and viral infections.Live attenuated and inactivated influenza vaccines in childrenAb and T cell epitopes of influenza A virus, knowledge and opportunitiesComparison of the influenza virus-specific effector and memory B-cell responses to immunization of children and adults with live attenuated or inactivated influenza virus vaccines.Mucosal model of immunization against human immunodeficiency virus type 1 with a chimeric influenza virusThe human side of influenza.The role of reverse genetics in the development of vaccines against respiratory viruses.New generation live vaccines against human respiratory syncytial virus designed by reverse genetics.Local and systemic cytokine and chemokine responses after parenteral influenza vaccination.NS1-truncated live attenuated virus vaccine provides robust protection to aged mice from viral challenge.Molecular and biological changes in the cold-adapted "master strain" A/AA/6/60 (H2N2) influenza virus.Protecting pediatric oncology patients from influenzaA "string-of-beads" vaccine, comprising linked minigenes, confers protection from lethal-dose virus challenge.Establishing the baseline burden of influenza in preparation for the evaluation of a countywide school-based influenza vaccination campaign.Correlates of Immunity to Influenza as Determined by Challenge of Children with Live, Attenuated Influenza VaccineAnalysis of immunoglobulin G antibody responses after administration of live and inactivated influenza A vaccine indicates that nasal wash immunoglobulin G is a transudate from serum.Local and systemic antibody responses in high-risk adults given live-attenuated and inactivated influenza A virus vaccinesNine μg intradermal influenza vaccine and 15 μg intramuscular influenza vaccine induce similar cellular and humoral immune responses in adults.Systemic and local antibody responses in elderly subjects given live or inactivated influenza A virus vaccinesEvaluation of cold-recombinant influenza A/Korea (CR-59) virus vaccine in infantsAntibody responses after inactivated influenza vaccine in young children.Use of live cold-adapted influenza A H1N1 and H3N2 virus vaccines in seropositive adultsIn elderly persons live attenuated influenza A virus vaccines do not offer an advantage over inactivated virus vaccine in inducing serum or secretory antibodies or local immunologic memoryEvaluation of bovine, cold-adapted human, and wild-type human parainfluenza type 3 viruses in adult volunteers and in chimpanzees.Targeting RSV with vaccines and small molecule drugs.Characteristics of vaccine failures in a randomized placebo-controlled trial of inactivated influenza vaccine in children.Mucosal immune responses predict clinical outcomes during influenza infection independently of age and viral load.
P2860
Q21563426-DD1A88A3-69BD-4E7D-8A76-C7EEF2B9E9B4Q24622008-9975B6AA-14F0-478C-8AE4-BBAB93E034D9Q26745547-F36E1C4A-E439-4AF2-94B6-82F0CFC2DFB5Q28743825-EA0827D3-649C-4DC2-85B8-14B2D3195278Q30411205-5A1A7920-EB44-46E2-B48A-2BFFA2B4C663Q30416288-F60D0306-B2E7-4BEF-9140-5631AC479F95Q33624415-C4FBD519-71D0-40D2-9CC2-268636510E66Q33690612-9FE0E5C6-7233-4248-B5A4-8EBD5DCD1AC7Q33776507-476BBED9-F166-4B8C-BBA8-B115C43FBF36Q33782441-8FF8069D-939F-4877-90B5-D738FADA9178Q33834576-35642E30-92B2-4CB1-8299-819954C0547BQ34093830-E77A5390-196C-4167-ABD6-A7661002B6C3Q34194475-F0B301B6-2B8F-44FC-95DE-32DC2C5E375EQ34259769-CC4C3673-49FE-47E2-8267-F818CF94A12BQ34974775-FCF47981-607A-4070-AF04-6423AF87E252Q35575957-6E6465E9-075B-4F70-B3A8-2DEF3DAA458EQ35634295-11C5F6B2-ACDE-4CB0-A324-0CB342AD6EE1Q35849627-BDAC4808-3003-4462-BFDB-283E26DBD348Q36055988-AF6866E6-D116-4157-B7FA-9717D8B17C28Q36099468-0455ED46-1356-41CA-9D8D-1B8A3B7C5710Q36237057-648B2A94-999B-4B4E-8D87-9B5BEFD12ACFQ36252434-17A55C6E-FE5F-4E4F-91BB-E3160F64B400Q36276683-43B3BA3C-47E2-4460-A687-9B3EC09A2578Q36390346-070567A2-AE03-4B1C-871F-255662C63565Q36630470-CE68BB33-247E-44C9-9E08-EF328E1774DBQ36639515-34E126B7-319F-4CB5-9A89-8A20DDE2CFC4Q36759964-E6786C18-51D7-43D9-B4FB-4DF7D2D8F24EQ37091608-10BD9DA9-BDDF-4F11-BE8C-F8BAA438955AQ37138345-2EF43B78-CF94-4756-AA65-EE07552C255FQ37149005-D25DB5ED-85F0-4BF1-AA00-DB681AB1C61FQ37159662-72D533B9-0D82-439C-9E97-9FF09C7922C7Q37163516-04B37A27-295C-433F-ACEA-9831719EBEC7Q37172722-F20E820D-9D8D-49CC-BC86-779984EB5001Q37173332-3DAE85EF-0D7C-4080-8085-49B2BB20863DQ37228291-4688D20E-CDD2-4385-8672-90233C33548DQ37231712-CD47DD84-5731-4CF0-8D35-FCDDC4992FFCQ37235698-1F75866B-AEAA-4879-BDCA-2C265A6DA478Q37328584-7F70A974-3DB8-4627-96BB-59822D727422Q37625970-628F0486-01BA-451E-9599-868534251533Q37688511-2C75AF72-B8F9-4E2A-B3A8-2B81AB24EA0C
P2860
Immunity to influenza A virus infection in young children: a comparison of natural infection, live cold-adapted vaccine, and inactivated vaccine.
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年学术文章
@wuu
1986年学术文章
@zh
1986年学术文章
@zh-cn
1986年学术文章
@zh-hans
1986年学术文章
@zh-my
1986年学术文章
@zh-sg
1986年學術文章
@yue
1986年學術文章
@zh-hant
name
Immunity to influenza A virus ...... cine, and inactivated vaccine.
@en
Immunity to influenza A virus ...... cine, and inactivated vaccine.
@nl
type
label
Immunity to influenza A virus ...... cine, and inactivated vaccine.
@en
Immunity to influenza A virus ...... cine, and inactivated vaccine.
@nl
prefLabel
Immunity to influenza A virus ...... cine, and inactivated vaccine.
@en
Immunity to influenza A virus ...... cine, and inactivated vaccine.
@nl
P2093
P356
P1476
Immunity to influenza A virus ...... cine, and inactivated vaccine.
@en
P2093
Johnson PR
Mahoney JD
Thompson JM
P304
P356
10.1093/INFDIS/154.1.121
P407
P577
1986-07-01T00:00:00Z